Sherbrooke Park Advisers’s UroGen Pharma URGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$229K	Buy	+16,747	New	+$229K	0.1%	361
2024 Q4	–	Sell	-28,393	Closed	-$361K	–	1175
2024 Q3	$361K	Buy	+28,393	New	+$361K	0.08%	484